National and Kapodistrian University of Athens
Κλινική σημασία της έκφρασης των υποδοχέων κανναβινοειδων CB-1 & CB-2 σε κακοήθη νεοπλάσματα νεφρού
Abstract
dc:descriptionIntroduction: In recent years there has been increasing discussion about the effect of cannabinoids on various forms of malignancy. Although it is proven, through laboratory studies, that cannabinoids play a role in malignancies such as breast cancer, prostate cancer and adenocarcinoma of the pancreas, there is insufficient research data on renal cell carcinoma. Aim: Evaluation of the expression of the cannabinoid CB1 (CB1R) and CB2 (CB2R) receptors (positivity, intensity, %, site of distribution, Immunohistochemical score) in renal cell carcinomas and their correlation with various clinicopathological aspects. Materials-Methods: We retrospectively obtained data and specimens from 87 patients diagnosed with renal cell carcinoma (RCC) after partial or radical nephrectomy and the CB1R and CB2R expression was assessed immunohistochemically on paraffin-embedded tissues. The results were statistically analyzed uni- and multi-factorial along with clinicopathological parameters. Results: CB1R was not expressed at all and the CB2R was highly expressed in n=78 (89.7%) patients with RCC. In Unifactorial analysis, no statistical significance was found in none of the analyzed parameters. However, in the multifactorial analysis, we found that patients with papillary histologic type (p<0.0005) were associated with lower likelihood of expression of the CB2R in the membranous compared with those with clear-cell and were also associated with higher likelihood of moderate or strong expression of CB2R Immunohistochemical score compared with those with clear-cell (p=0.03). Patients with Stage T2 (p=0.010) had more enhanced expression (grade 3 CB2R intensity) compared with those with Stage T1. Males (Beta coefficient ± SE: 13.70±7.04; p=0.056) and patients with chromophobe histological type (Beta coefficient ± SE: 23.45±9.86;p=0.020) were associated with higher percentage of CB2R.88Conclusions: Our data suggest that CB2R, after well-designed studies, especially the CB2R could be used as a prognostic marker or even as a potential therapeutic target in RCC.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2024
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Deligiannis, Dimitrios
- Δεληγιάννης, Δημήτριος
Subjects
dc:subject × 16- Νεφροκυτταρικό καρκίνωμα
- Πρόγνωση καρκίνου νεφρού
- Υποδοχείς κανναβινοειδών
- CB-1 υποδοχέας
- CB-2 υποδοχέας
- Renal cell carcinoma
- Prognosis of renal cell carcinoma
- Cannabinoids
- CB-1 receptor
- CB-2 receptor
- Επιστήμες Υγείας
- Ιατρική και Επιστήμες Υγείας
- Επιστήμες υγείας, γενικά
- Health Sciences
- Medical and Health Sciences
- Health sciences, general
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/56087